BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ticci C, Cassandrini D, Rubegni A, Riva B, Vattemi G, Matà S, Ricci G, Baldacci J, Guglielmi V, Di Muzio A, Malandrini A, Tonin P, Siciliano G, Federico A, Genazzani AA, Santorelli FM, Merlini L. Expanding the clinical and genetic spectrum of pathogenic variants in STIM1. Muscle Nerve 2021. [PMID: 34368974 DOI: 10.1002/mus.27391] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 de la Fuente-munoz E, Van Den Rym A, García-solis B, Ochoa Grullón J, Guevara-hoyer K, Fernández-arquero M, Galán Dávila L, Matías-guiú J, Sánchez-ramón S, Pérez de Diego R. Case Report: Novel STIM1 Gain-of-Function Mutation in a Patient With TAM/STRMK and Immunological Involvement. Front Immunol 2022;13:917601. [DOI: 10.3389/fimmu.2022.917601] [Reference Citation Analysis]
2 Riva B, Pessolano E, Quaglia E, Cordero-sanchez C, Bhela IP, Topf A, Serafini M, Cox D, Harris E, Garibaldi M, Barresi R, Pirali T, Genazzani AA. STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca2+-entry modulators CIC-37 and CIC-39. Cell Calcium 2022. [DOI: 10.1016/j.ceca.2022.102605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]